PDI Reports 2009 Third Quarter Financi...($73600 $81639 ...),Health

Date:11/5/2009

$73,600 $81,639 ------- ------- Total assets $124,925 $149,036 Total liabilities $31,781 $41,929 Total stockholders' equity $93,144 $107,107 Selected Cash Flow Data (Unaudited) (in thousands) September 30, September 30, 2009 2008 ---- ---- Net loss $(15,112) $(17,541) Non-cash items 4,605 4,992 Net change in assets and liabilities (8,371) 6,229 ------ ----- Net cash used in operations $(18,878) $(6,320) Change in cash and cash equivalents $(19,523) $(4,875)

Exhibit A

Non-GAAP Financial Measures

When we evaluate the performance of our business as a whole, we focus on results (such as gross profit, operating expense and operating income/loss) before certain types of gains and charges because such gains and charges are not a component of our ongoing income or expenses and/or may have a disproportionate positive or negative impact on the results of our ongoing underlying business operations. These non-GAAP results should not be considered in isolation and are not in accordance with, or a substitute for, GAAP results. Our non-GAAP results may differ from similar measures used by other companies, even if similar terms are used to identify such measures. PDI's management believes non-GAAP results are useful in evaluating the performance of its business; however, its reliance on these measures is limited since items excluded from such m
'/>"/>

SOURCE PDI, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine technology :

1. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
4. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
5. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. HeartWare International Reports Third Quarter Revenues of $7.5 Million
7. Varian, Inc. Reports Fourth Quarter 2009 Results
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10. Cambrex Reports Third Quarter 2009 Results
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results